[en] It is at present well established that prolactin exerts a non-specific immunoactivating function. In this work we tested whether the immunosuppressant drugs cyclosporin A, FK506 and rapamycin influence prolactin release from rat pituitary cells in primary culture. The tested drugs had no effect on the prolactin release measured during a 2h incubation period, indicating that they do not influence the secretion of prolactin from intracellular stores into the culture medium. During longer incubation times (48h), however, prolactin release was diminished to 56% +/- 18 (10 microM cyclosporin A), 64% +/- 14 (1 microM rapamycin) or 64% +/- 7 (1 microM FK506), suggesting an effect on prolactin production. At these drug concentrations no toxic effects were observed. The data indicate that inhibition of pituitary prolactin synthesis might contribute to the immunosuppressant action of cyclosporin A, rapamycin and FK506.
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Wera, S.
Zheng, L.
Hooghe-Peters, E. L.
Belayew, A.
Martial, Joseph ; Université de Liège - ULiège > Département des sciences de la vie > GIGA-R : Biologie et génétique moléculaire
Velkeniers, B.
Language :
English
Title :
Cyclosporin A, rapamycin and FK506 decrease prolactin release from rat pituitary cells in primary culture
Publication date :
1995
Journal title :
Endocrine Research
ISSN :
0743-5800
eISSN :
1532-4206
Publisher :
Taylor & Francis, Philadelphia, United States - Pennsylvania
Hooghe R. Delhase M. Vergani P. Malur A. Hooghe-Peters EL. 1993 Growth hormone and prolactin are paracrine growth and differentiation factors in the haemopoietic system. Immunol. Today 14: 212-214
Viselli S. M. Stanek EM. Mukherjee P. Hymer W. C., Mastro A. M. 1991 Prolactin-induced mitogenesis of lymphocytes from ovariectomized rats. Endocrinol. 129, 983-990
Russel D. H. Mills KT. Talamantes F. J. Bern H. A. 1988 Neonatal administration of prolactin antiserum alters the developmental pattern of T and B lymphocytes in the thymus and spleen of BALB/C female mice. Proc. Natl. Acad. Sci. USA 85: 7404-7407
Pellegrini I. Lebrun J. J. Ali S. Kelly P. A. 1992 Expression of prolactin and its receptor in human lymphoid cells. Mol. Endocrinol. 6: 1023-1031
Liu J. Farmer I. D. Lane W.S. Friedman J. Weisman I. Schreiber S.L. 1991 Calcineurin is a common target of cyclophilin-cyclosporin A and FK506-FKBP complexes. Cell 66: 807-815
Liu J. Alberts MW. Wandless T. J. Luan S. Alberg D. C., Belshaw D. J. Cohen P. Mackintosh C., Klee C. D. Schreiber S.L. 1992 Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity. Biochemistry 31: 3896-3901
Schreiber S. Crabtree G. R. 1992 The mechanism of action of cyclosporin A and FK506. Immunol. Today 13: 136-142
Wera S. Belayew A. Martial J. A. 1995 Rapamycin, FK506 and cyclosporin A inhibit human prolactin gene expression. FEBS L. 358: 158-160
Denef C., Hautekeete E. De Wolf A. Verscheuren B. 1978 Pituitary basophils from mature male and female rats. Distribution of gonadotrophs and thyrotrophs as studied by unit gravity sedimentation. Endocrinol. 103: 724-735
Velkeniers B. Hooghe-Peters EL. Hooghe R. Belayew A. Smets G., Claeys A., Robberecht P. Vanhaelst L. 1988 Prolactin cell subpopulations separated on percoll gradient: An immunocytochemical, biochemical and physiological characterization. Endocrinol. 123: 1619-1630
Berwaer M. Monget P. Peers B. Mathy-Hartert M. Bellefroid E. Davis JRE. Belayew A. Martial J. A. 1991 Multihormonal regulation of the human prolactin gene expression from 5000 bp of its upstream sequence. Mol. Cell. Endocrinol. 80: 53-64
Larson D. F. Copeland JG. Russel D.H. 1985 Prolactin predicts cardiac allograft rejection in cyclosporin immunosuppressed patients. Lancet 8445 July 6, 53